NewAmsterdam Pharma Co NV (NAMS.O)

+ 收藏

资产负债表(NewAmsterdam Pharma Co NV)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2025年中报2025年一季报2024年年报2024年三季报2024年中报2024年一季报
截止日期 2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表
报表年结日 123112311231123112311231
原始币种 美元美元美元美元美元美元
上市前/上市后 上市后上市后上市后上市后上市后上市后
流动资产:
 现金及现金等价物(元) 会员可见会员可见会员可见会员可见430,708,000.00481,147,000.00
 应收账款及票据(元) --会员可见---
 预付款项及其他应收款流动(元) 会员可见会员可见会员可见会员可见14,644,000.006,675,000.00
 短期投资(元) 会员可见会员可见会员可见---
 流动资产合计(元) 会员可见会员可见会员可见会员可见445,352,000.00487,822,000.00
非流动资产:
 物业、厂房及设备(元) 会员可见会员可见会员可见会员可见234,000.00101,000.00
 无形资产(元) 会员可见会员可见会员可见会员可见542,000.00486,000.00
 预付款项及其他长期应收款非流动(元) ----8,000.0016,000.00
 长期投资(元) 会员可见-----
 非流动资产其他项目(元) 会员可见会员可见会员可见会员可见554,000.0038,000.00
 非流动资产合计(元) 会员可见会员可见会员可见会员可见1,338,000.00641,000.00
总资产(元) 会员可见会员可见会员可见会员可见446,690,000.00488,463,000.00
流动负债:
 融资租赁负债流动(元) 会员可见会员可见会员可见会员可见234,000.0043,000.00
 应付账款及票据(元) 会员可见会员可见会员可见会员可见5,275,000.008,536,000.00
 其他应付款及应计费用(元) 会员可见会员可见会员可见会员可见10,194,000.009,970,000.00
 衍生工具负债流动(元) 会员可见会员可见会员可见会员可见23,545,000.0033,061,000.00
 递延收入流动(元) -会员可见会员可见会员可见6,059,000.008,116,000.00
 流动负债合计(元) 会员可见会员可见会员可见会员可见45,307,000.0059,726,000.00
非流动负债:
 融资租赁负债非流动(元) 会员可见会员可见会员可见会员可见328,000.00-
 衍生工具负债非流动(元) ---会员可见13,394,000.0016,490,000.00
 递延收入非流动(元) ----222,000.00444,000.00
 非流动负债合计(元) 会员可见会员可见会员可见会员可见13,944,000.0016,934,000.00
总负债(元) 会员可见会员可见会员可见会员可见59,251,000.0076,660,000.00
股东权益:
 普通股(元) 会员可见会员可见会员可见会员可见11,151,000.0011,113,000.00
 股本溢价(元) 会员可见会员可见会员可见会员可见821,613,000.00807,008,000.00
 留存收益(元) 会员可见会员可见会员可见会员可见-449,747,000.00-410,740,000.00
 累计其他全面收益(元) 会员可见会员可见会员可见会员可见4,422,000.004,422,000.00
 归属于母公司股东权益(元) 会员可见会员可见会员可见会员可见387,439,000.00411,803,000.00
 股东权益合计(元) 会员可见会员可见会员可见会员可见387,439,000.00411,803,000.00
负债及股东权益合计(元) 会员可见会员可见会员可见会员可见446,690,000.00488,463,000.00
公告日期 2025-08-062025-05-082025-02-262024-11-062024-08-072024-05-08
会计准则 美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则
审计意见
核数师

前瞻产业研究院